GORDONSVILLE, Va., April 21 /PRNewswire/ -- A new study funded by Health Canada and other organizations has proven a direct correlation between dietary consumption of the omega-3 DHA* and enhanced infant development. The study, which was supervised by Universite Laval researchers and published in the Journal of Pediatrics, reveals DHA consumed during the last months of pregnancy boosts an infant's sensory, cognitive, and motor development.
The research team reached its conclusion by first measuring the amount of DHA concentration in the umbilical cord blood of 109 infants.
"DHA concentration in the umbilical cord is a good indicator of intra-uterine exposure to omega-3s during the last trimester of pregnancy, a crucial period for the development of retinal photoreceptors and neurons," said study supervisor Dr. Eric Dewailly.**
After testing the infants at six and 11 months, the researchers discovered visual acuity, cognitive development, and motor development were closely linked to DHA concentration in the umbilical cord blood at the time of their birth.
Renowned DHA expert Barbara S. Levine, R.D., Ph.D., director of the first NIH-funded Nutrition Information Center at Weill Cornell Medical College, believes the study's findings support the overall significance of an expectant mother's diet.
"For years researchers and nutritional experts have studied the importance of DHA in a pregnant woman's diet and the resulting impact these essential nutrients have on the development of her fetus," said Dr. Levine. "In addition to folic acid, which helps prevent the development of spinal bifida and other birth defects, it is necessary for expectant mother's to include DHA in their diets for brain and eye development."
Dr. Levine is a scientific advisory board member of http://www.dhaandbvitamins.org, an educational Web site developed by specialists at Weill Cornell Medical College and other major academic medical centers. She has been recommending the nutritional supplement Animi-3 to patients who need to supplement their diets with DHA and B vitamins.
"Physicians are using Animi-3 to deliver DHA, folic acid, and other vital nutrients to pregnant and nursing women, as well as new mothers with postpartum depression," said PBM Pharmaceuticals President Jack Schramm. "The DHA in Animi-3 is all natural and purified to eliminate any contaminants including those commonly found in fish."
Each capsule of Animi-3 contains 500 mg of omega-3 acids, including 350 mg of DHA. For more information, visit http://www.animi-3.com.
**Source: Universite Laval.
Retrieved April 11, 2008, from
pendant-les-derniers-mois-852.html?an=1 (due to the length of the URL,
please copy and paste into web browser)
Animi-3 is not intended to diagnose, treat, or cure any disease.
Contact: Joe Shields
Director of Public Relations
(800) 959-2066 ext. 131
|SOURCE PBM Pharmaceuticals|
Copyright©2008 PR Newswire.
All rights reserved